We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
-3.69%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
AUM
$860K
AUM Growth
+$27.7K
Cap. Flow
+$69.5K
Cap. Flow %
8.09%
Top 10 Hldgs %
100%
Holding
3
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$69.5K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
1
Castle Biosciences
CSTL
$949M
$800K 93.07%
36,747
+3,121
+9% +$69.5K
WHWK
2
Whitehawk Therapeutics
WHWK
$208M
$38.9K 4.53%
26,666
SYBX
3
DELISTED
Synlogic
SYBX
$20.6K 2.4%
13,727

Similar funds

ABG Innovation Capital Partners III's Q2 2024 Portfolio in Review

As of Q2 2024, ABG Innovation Capital Partners III held 3 positions worth $860K, up 3.3% from $832K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG Innovation Capital Partners III deployed $69.5K of net new capital in Q2 2024, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III added most to Castle Biosciences in Q2 2024, an estimated $69.5K increase.
  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $860K portfolio in Q2 2024.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 0 in Q2 2024.
  • ABG Innovation Capital Partners III's portfolio value rose 3.3% quarter-over-quarter to $860K.

Based on ABG Innovation Capital Partners III's 13F filing for Q2 2024, filed 14 Aug 2024.